메뉴 건너뛰기




Volumn 261, Issue 12, 2014, Pages 2251-2263

Dopamine receptor mapping with PET imaging in Parkinson’s disease

Author keywords

D1 receptors; D2 receptors; Dopamine; Parkinson s disease; PET; Raclopride

Indexed keywords


EID: 84895853793     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7302-2     Document Type: Review
Times cited : (41)

References (100)
  • 1
    • 66949152096 scopus 로고    scopus 로고
    • Parkinson’s disease
    • COI: 1:CAS:528:DC%2BD1MXnt1ans7w%3D, PID: 19524782
    • Lees AJ, Hardy J, Revesz T (2009) Parkinson’s disease. Lancet 373(9680):2055–2066
    • (2009) Lancet , vol.373 , Issue.9680 , pp. 2055-2066
    • Lees, A.J.1    Hardy, J.2    Revesz, T.3
  • 2
    • 0020375803 scopus 로고
    • Basal ganglia disease
    • COI: 1:CAS:528:DyaL3sXktVemurk%3D, PID: 6128460
    • Marsden CD (1982) Basal ganglia disease. Lancet 2(8308):1141–1147
    • (1982) Lancet , vol.2 , Issue.8308 , pp. 1141-1147
    • Marsden, C.D.1
  • 3
    • 0026348872 scopus 로고
    • Pathology of Parkinson’s disease
    • Jellinger KA (1991) Pathology of Parkinson’s disease. Mol Chem Neuropathol 3:153–197
    • (1991) Mol Chem Neuropathol , vol.3 , pp. 153-197
    • Jellinger, K.A.1
  • 4
    • 2542596183 scopus 로고    scopus 로고
    • Parkinson’s disease
    • COI: 1:CAS:528:DC%2BD2cXksVanu7k%3D, PID: 15172778
    • Samii A, Nutt JG, Ransom BR (2004) Parkinson’s disease. Lancet 363(9423):1783–1793
    • (2004) Lancet , vol.363 , Issue.9423 , pp. 1783-1793
    • Samii, A.1    Nutt, J.G.2    Ransom, B.R.3
  • 5
    • 0033836912 scopus 로고    scopus 로고
    • Motor impairment in Parkinson’s disease: relationship to incident dementia and age
    • COI: 1:STN:280:DC%2BD3cvhsV2qug%3D%3D, PID: 10953188
    • Levy G, Tang MX, Cote LJ, Louise ED, Alfaro B, Mejia H, Stern Y, Marder K (2000) Motor impairment in Parkinson’s disease: relationship to incident dementia and age. Neurology 55:539–544
    • (2000) Neurology , vol.55 , pp. 539-544
    • Levy, G.1    Tang, M.X.2    Cote, L.J.3    Louise, E.D.4    Alfaro, B.5    Mejia, H.6    Stern, Y.7    Marder, K.8
  • 6
    • 0030271126 scopus 로고    scopus 로고
    • Basal ganglia and movement disorders: an update
    • Chesselet MF, Delfs JM (1999) Basal ganglia and movement disorders: an update. Trends Neurosci 19:417–422
    • (1999) Trends Neurosci , vol.19 , pp. 417-422
    • Chesselet, M.F.1    Delfs, J.M.2
  • 7
    • 0038727939 scopus 로고    scopus 로고
    • Physiology and pathophysiology of Parkinson’s disease
    • PID: 12846970
    • Hamani C, Lozano AM (2003) Physiology and pathophysiology of Parkinson’s disease. Ann NY Acad Sci 991:15–21
    • (2003) Ann NY Acad Sci , vol.991 , pp. 15-21
    • Hamani, C.1    Lozano, A.M.2
  • 8
    • 84867337416 scopus 로고    scopus 로고
    • Positron emission tomography imaging in neurological disorders
    • PID: 22297461
    • Politis M, Piccini P (2012) Positron emission tomography imaging in neurological disorders. J Neurol 259(9):1769–1780
    • (2012) J Neurol , vol.259 , Issue.9 , pp. 1769-1780
    • Politis, M.1    Piccini, P.2
  • 9
    • 0034241796 scopus 로고    scopus 로고
    • Positron emission tomography provides molecular imaging of biological processes
    • COI: 1:CAS:528:DC%2BD3cXls12ksb8%3D, PID: 10922074
    • Phelps ME (2000) Positron emission tomography provides molecular imaging of biological processes. PNAS 97:9226–9233
    • (2000) PNAS , vol.97 , pp. 9226-9233
    • Phelps, M.E.1
  • 10
    • 0022929679 scopus 로고
    • Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography
    • COI: 1:CAS:528:DyaL2sXosVekug%3D%3D, PID: 3027000
    • Halldin C, Stone-Elander S, Farde L, Ehrin E, Fasth KJ, Långström B, Sedvall G (1986) Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography. Int J Rad Appl Instrum A 37(10):1039–1043
    • (1986) Int J Rad Appl Instrum A , vol.37 , Issue.10 , pp. 1039-1043
    • Halldin, C.1    Stone-Elander, S.2    Farde, L.3    Ehrin, E.4    Fasth, K.J.5    Långström, B.6    Sedvall, G.7
  • 11
    • 34748858652 scopus 로고    scopus 로고
    • [11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT(2A) receptors: a PET study in healthy human subjects
    • COI: 1:CAS:528:DC%2BD2sXhtVKhtrjE, PID: 17311076
    • Slifstein M, Kegeles LS, Gonzales R, Frankle WG, Xu X, Laruelle M, Abi-Dargham A (2007) [11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT(2A) receptors: a PET study in healthy human subjects. J Cereb Blood Flow Metab 27(10):1733–1741
    • (2007) J Cereb Blood Flow Metab , vol.27 , Issue.10 , pp. 1733-1741
    • Slifstein, M.1    Kegeles, L.S.2    Gonzales, R.3    Frankle, W.G.4    Xu, X.5    Laruelle, M.6    Abi-Dargham, A.7
  • 12
    • 0032881922 scopus 로고    scopus 로고
    • A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain
    • COI: 1:CAS:528:DyaK1MXntlOmtbg%3D, PID: 10525759
    • Chou YH, Karlsson P, Halldin C, Olsson H, Farde L (1999) A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain. Psychopharmacology 146(2):220–227
    • (1999) Psychopharmacology , vol.146 , Issue.2 , pp. 220-227
    • Chou, Y.H.1    Karlsson, P.2    Halldin, C.3    Olsson, H.4    Farde, L.5
  • 14
    • 0032752306 scopus 로고    scopus 로고
    • Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson’s disease: a double-tracer positron emission tomography study
    • COI: 1:STN:280:DC%2BD3c%2FhvFCitQ%3D%3D, PID: 10553989
    • Ouchi Y, Kanno T, Okada H, Yoshikawa E, Futatsubashi M, Nobezawa S, Torizuka T, Sakamoto M (1999) Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson’s disease: a double-tracer positron emission tomography study. Ann Neurol 46(5):723–731
    • (1999) Ann Neurol , vol.46 , Issue.5 , pp. 723-731
    • Ouchi, Y.1    Kanno, T.2    Okada, H.3    Yoshikawa, E.4    Futatsubashi, M.5    Nobezawa, S.6    Torizuka, T.7    Sakamoto, M.8
  • 15
    • 0035809803 scopus 로고    scopus 로고
    • Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson’s disease
    • COI: 1:CAS:528:DC%2BD3MXhs1eisLg%3D, PID: 11245931
    • Hurley MJ, Mash DC, Jenner P (2001) Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson’s disease. Brain Res Mol Brain Res 87(2):271–279
    • (2001) Brain Res Mol Brain Res , vol.87 , Issue.2 , pp. 271-279
    • Hurley, M.J.1    Mash, D.C.2    Jenner, P.3
  • 16
    • 0027264960 scopus 로고
    • Dopamine D1 receptors in Parkinson’s disease and striatonigral degeneration: a positron emission tomography study
    • COI: 1:STN:280:DyaK3s3otVGrug%3D%3D, PID: 8505636
    • Shinotoh H, Inoue O, Hirayama K, Aotsuka A, Asahina M, Suhara T, Yamazaki T, Tateno Y (1993) Dopamine D1 receptors in Parkinson’s disease and striatonigral degeneration: a positron emission tomography study. J Neurol Neurosurg Psychiatry 56(5):467–472
    • (1993) J Neurol Neurosurg Psychiatry , vol.56 , Issue.5 , pp. 467-472
    • Shinotoh, H.1    Inoue, O.2    Hirayama, K.3    Aotsuka, A.4    Asahina, M.5    Suhara, T.6    Yamazaki, T.7    Tateno, Y.8
  • 17
    • 0030827709 scopus 로고    scopus 로고
    • In vivo studies on striatal dopamine D1 and D2 site binding in L-DOPA treated Parkinson’s disease patients with and without dyskinesias
    • COI: 1:CAS:528:DyaK2sXmtlOmtL8%3D, PID: 9305330
    • Turjanski N, Lees AJ, Brooks DJ (1997) In vivo studies on striatal dopamine D1 and D2 site binding in L-DOPA treated Parkinson’s disease patients with and without dyskinesias. Neurology 49:717–723
    • (1997) Neurology , vol.49 , pp. 717-723
    • Turjanski, N.1    Lees, A.J.2    Brooks, D.J.3
  • 18
    • 44649129998 scopus 로고    scopus 로고
    • Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA
    • COI: 1:CAS:528:DC%2BD1cXmvFSmt7o%3D, PID: 18504119
    • Cropley VL, Fujita M, Bara-Jimenez W, Brown AK, Zhang XY, Sangare J, Herscovitch P, Pike VW, Hallett M, Nathan PJ, Innis RB (2008) Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA. Psychiatry Res 163(2):171–182
    • (2008) Psychiatry Res , vol.163 , Issue.2 , pp. 171-182
    • Cropley, V.L.1    Fujita, M.2    Bara-Jimenez, W.3    Brown, A.K.4    Zhang, X.Y.5    Sangare, J.6    Herscovitch, P.7    Pike, V.W.8    Hallett, M.9    Nathan, P.J.10    Innis, R.B.11
  • 22
    • 0013277610 scopus 로고
    • Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography
    • COI: 1:CAS:528:DyaL2MXkvVChsb4%3D, PID: 3873656
    • Farde L, Ehrin E, Eriksson L, Greitz T, Hall H, Hedström CG, Litton JE, Sedvall G (1985) Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci USA 82(11):3863–3867
    • (1985) Proc Natl Acad Sci USA , vol.82 , Issue.11 , pp. 3863-3867
    • Farde, L.1    Ehrin, E.2    Eriksson, L.3    Greitz, T.4    Hall, H.5    Hedström, C.G.6    Litton, J.E.7    Sedvall, G.8
  • 23
    • 0025338472 scopus 로고
    • Production of 3-N-[11C]methylspiperone with high specific activity and high radiochemical purity for PET studies: suppression of its radiolysis
    • COI: 1:CAS:528:DyaK3cXlt1yksLY%3D, PID: 1972936
    • Suzuki K, Inoue O, Tamate K, Mikado F (1990) Production of 3-N-[11C]methylspiperone with high specific activity and high radiochemical purity for PET studies: suppression of its radiolysis. Int J Rad Appl Instrum A 41(6):593–599
    • (1990) Int J Rad Appl Instrum A , vol.41 , Issue.6 , pp. 593-599
    • Suzuki, K.1    Inoue, O.2    Tamate, K.3    Mikado, F.4
  • 24
    • 0030593323 scopus 로고    scopus 로고
    • 18F-desmethoxyfallypride: a fluorine-18 labeled radiotracer with properties similar to carbon-11 raclopride for PET imaging studies of dopamine D2 receptors
    • COI: 1:CAS:528:DyaK28Xks1altb0%3D, PID: 8761017
    • Mukherjee J, Yang ZY, Brown T, Roemer J, Cooper M (1996) 18F-desmethoxyfallypride: a fluorine-18 labeled radiotracer with properties similar to carbon-11 raclopride for PET imaging studies of dopamine D2 receptors. Life Sci 59(8):669–678
    • (1996) Life Sci , vol.59 , Issue.8 , pp. 669-678
    • Mukherjee, J.1    Yang, Z.Y.2    Brown, T.3    Roemer, J.4    Cooper, M.5
  • 25
    • 34548543972 scopus 로고    scopus 로고
    • In vitro affinities of various halogenated benzamide derivatives as potential radioligands for non-invasive quantification of D(2)-like dopamine receptors
    • COI: 1:CAS:528:DC%2BD2sXhtVCitr%2FM, PID: 17765546
    • Stark D, Piel M, Hübner H, Gmeiner P, Gründer G, Rösch F (2007) In vitro affinities of various halogenated benzamide derivatives as potential radioligands for non-invasive quantification of D(2)-like dopamine receptors. Bioorg Med Chem 15(21):6819–6829
    • (2007) Bioorg Med Chem , vol.15 , Issue.21 , pp. 6819-6829
    • Stark, D.1    Piel, M.2    Hübner, H.3    Gmeiner, P.4    Gründer, G.5    Rösch, F.6
  • 26
    • 0033623451 scopus 로고    scopus 로고
    • (-)-N-[(11)C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D(2) receptors
    • COI: 1:CAS:528:DC%2BD3cXosVWltbw%3D, PID: 11056366
    • Hwang DR, Kegeles LS, Laruelle M (2000) (-)-N-[(11)C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D(2) receptors. Nucl Med Biol 27(6):533–539
    • (2000) Nucl Med Biol , vol.27 , Issue.6 , pp. 533-539
    • Hwang, D.R.1    Kegeles, L.S.2    Laruelle, M.3
  • 28
    • 0034018859 scopus 로고    scopus 로고
    • Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review
    • COI: 1:CAS:528:DC%2BD3cXisVegurk%3D, PID: 10724107
    • Laruelle M (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20:423–451
    • (2000) J Cereb Blood Flow Metab , vol.20 , pp. 423-451
    • Laruelle, M.1
  • 29
    • 0032703626 scopus 로고    scopus 로고
    • Striatal D2 dopamine receptor status in Parkinson’s disease: an 18F DOPA and 11C-raclopride PET study
    • COI: 1:STN:280:DC%2BD3c%2FkvFektQ%3D%3D, PID: 10584682
    • Dentresangle C, Veyre L, le Bars Pierre C, Lavenne F, Pollak P, Guerin J, Froment JC, Brousolle E (1999) Striatal D2 dopamine receptor status in Parkinson’s disease: an 18F DOPA and 11C-raclopride PET study. Mov Disord 14(6):1025–1030
    • (1999) Mov Disord , vol.14 , Issue.6 , pp. 1025-1030
    • Dentresangle, C.1    Veyre, L.2    le Bars, P.C.3    Lavenne, F.4    Pollak, P.5    Guerin, J.6    Froment, J.C.7    Brousolle, E.8
  • 30
    • 0033957270 scopus 로고    scopus 로고
    • Upregulation of putaminal dopamine D2 receptors in early Parkinson’s disease: a comparative PET study with 11C-raclopride and 11C-methylspiperone
    • COI: 1:CAS:528:DC%2BD3cXotVSqtQ%3D%3D, PID: 10647606
    • Kaasinen V, Ruottinen HM, Nagren K, Lehikoinen P, Oikonen V, Rinne JO (2000) Upregulation of putaminal dopamine D2 receptors in early Parkinson’s disease: a comparative PET study with 11C-raclopride and 11C-methylspiperone. J Nucl Med 41:65–70
    • (2000) J Nucl Med , vol.41 , pp. 65-70
    • Kaasinen, V.1    Ruottinen, H.M.2    Nagren, K.3    Lehikoinen, P.4    Oikonen, V.5    Rinne, J.O.6
  • 31
    • 0027246667 scopus 로고
    • Asymmetrical presynaptic and postsynaptic changes in the striatal dopamine projection in Dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status
    • PID: 8353712
    • Sawle GV, Playford ED, Brooks DJ, Quinn N, Frackowiak RS (1993) Asymmetrical presynaptic and postsynaptic changes in the striatal dopamine projection in Dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status. Brain 116:853–867
    • (1993) Brain , vol.116 , pp. 853-867
    • Sawle, G.V.1    Playford, E.D.2    Brooks, D.J.3    Quinn, N.4    Frackowiak, R.S.5
  • 32
    • 0031031846 scopus 로고    scopus 로고
    • Long-term changes of striatal dopamine D2 receptors in patients with Parkinson’s disease: a study with positron emission tomography and [11C]raclopride
    • COI: 1:STN:280:DyaK2s7ksVahtw%3D%3D, PID: 8990051
    • Antonini A, Schwarz J, Oertel WH, Pogarell O, Leenders KL (1997) Long-term changes of striatal dopamine D2 receptors in patients with Parkinson’s disease: a study with positron emission tomography and [11C]raclopride. Mov Disord 12(1):33–38
    • (1997) Mov Disord , vol.12 , Issue.1 , pp. 33-38
    • Antonini, A.1    Schwarz, J.2    Oertel, W.H.3    Pogarell, O.4    Leenders, K.L.5
  • 33
    • 0025612448 scopus 로고
    • PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson’s disease
    • COI: 1:CAS:528:DyaK3MXnvFGqsA%3D%3D, PID: 1981915
    • Rinne JO, Laihinen A, Någren K, Bergman J, Solin O, Haaparanta M, Ruotsalainen U, Rinne UK (1990) PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson’s disease. J Neurosci Res 27(4):494–499
    • (1990) J Neurosci Res , vol.27 , Issue.4 , pp. 494-499
    • Rinne, J.O.1    Laihinen, A.2    Någren, K.3    Bergman, J.4    Solin, O.5    Haaparanta, M.6    Ruotsalainen, U.7    Rinne, U.K.8
  • 34
    • 0027176890 scopus 로고
    • PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson’s disease
    • COI: 1:STN:280:DyaK3s3jtlKrug%3D%3D, PID: 8474478
    • Rinne JO, Laihinen A, Rinne UK, Någren K, Bergman J, Ruotsalainen U (1993) PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson’s disease. Mov Disord 8(2):134–138
    • (1993) Mov Disord , vol.8 , Issue.2 , pp. 134-138
    • Rinne, J.O.1    Laihinen, A.2    Rinne, U.K.3    Någren, K.4    Bergman, J.5    Ruotsalainen, U.6
  • 35
    • 0029126115 scopus 로고
    • Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson’s disease: a PET study with [11C]raclopride
    • COI: 1:CAS:528:DyaK2MXptlWqtb0%3D, PID: 8543941
    • Rinne JO, Laihinen A, Ruottinen H, Ruotsalainen U, Någren K, Lehikoinen P, Oikonen V, Rinne UK (1995) Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson’s disease: a PET study with [11C]raclopride. J Neurol Sci 132(2):156–161
    • (1995) J Neurol Sci , vol.132 , Issue.2 , pp. 156-161
    • Rinne, J.O.1    Laihinen, A.2    Ruottinen, H.3    Ruotsalainen, U.4    Någren, K.5    Lehikoinen, P.6    Oikonen, V.7    Rinne, U.K.8
  • 36
    • 0030175258 scopus 로고    scopus 로고
    • Unilateral 6 hydroxy dopamine lesions in meso striatal dopamine neurons and their physiological sequelae
    • COI: 1:CAS:528:DyaK28XlvFKrt74%3D, PID: 8878304
    • Schwarting RK, Huston JP (1996) Unilateral 6 hydroxy dopamine lesions in meso striatal dopamine neurons and their physiological sequelae. Prog Neurobiol 49:215–266
    • (1996) Prog Neurobiol , vol.49 , pp. 215-266
    • Schwarting, R.K.1    Huston, J.P.2
  • 37
    • 0026612088 scopus 로고
    • Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography
    • COI: 1:STN:280:DyaK383ks1ClsQ%3D%3D, PID: 1575457
    • Brooks DJ, Ibanez V, Saule GV, Playford ED, Quinn N, Mathias CJ, Lees AJ, Marsden CD, Bannister R, Frackowiak RS (1992) Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol 31:184–192
    • (1992) Ann Neurol , vol.31 , pp. 184-192
    • Brooks, D.J.1    Ibanez, V.2    Saule, G.V.3    Playford, E.D.4    Quinn, N.5    Mathias, C.J.6    Lees, A.J.7    Marsden, C.D.8    Bannister, R.9    Frackowiak, R.S.10
  • 38
    • 0028168112 scopus 로고
    • [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson’s disease: influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors
    • COI: 1:STN:280:DyaK2czgvFyhsg%3D%3D, PID: 8035939
    • Antonini A, Schwarz J, Oertel WH, Beer HF, Madeja UD, Leenders KL (1994) [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson’s disease: influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors. Neurology 44(7):1325–1329
    • (1994) Neurology , vol.44 , Issue.7 , pp. 1325-1329
    • Antonini, A.1    Schwarz, J.2    Oertel, W.H.3    Beer, H.F.4    Madeja, U.D.5    Leenders, K.L.6
  • 40
    • 0024593812 scopus 로고
    • Asymmetry of substantia nigra neuronal loss in Parkinson’s disease and its relevance to the mechanism of levodopa related motor fluctuations
    • COI: 1:STN:280:DyaL1M3hsFyktA%3D%3D, PID: 2709038
    • Kempster PA, Gibb WRG, Stern GM, Lees AJ (1989) Asymmetry of substantia nigra neuronal loss in Parkinson’s disease and its relevance to the mechanism of levodopa related motor fluctuations. J Neurol Neurosurg Psychiatry 52:72–76
    • (1989) J Neurol Neurosurg Psychiatry , vol.52 , pp. 72-76
    • Kempster, P.A.1    Gibb, W.R.G.2    Stern, G.M.3    Lees, A.J.4
  • 42
    • 0027415104 scopus 로고
    • Dopamine D3 receptor mRNA and binding sites in human brain
    • COI: 1:CAS:528:DyaK3sXmtFOqtrs%3D, PID: 8097550
    • Landwehrmeyer B, Mengod G, Palacios JM (1993) Dopamine D3 receptor mRNA and binding sites in human brain. Brain Res Mol Brain Res 18:187–192
    • (1993) Brain Res Mol Brain Res , vol.18 , pp. 187-192
    • Landwehrmeyer, B.1    Mengod, G.2    Palacios, J.M.3
  • 43
    • 0028173396 scopus 로고
    • Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain
    • COI: 1:CAS:528:DyaK2cXmvFems70%3D, PID: 7972046
    • Murray AM, Ryoo HL, Gurevich E, Joyce JN (1994) Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci USA 91:11271–11275
    • (1994) Proc Natl Acad Sci USA , vol.91 , pp. 11271-11275
    • Murray, A.M.1    Ryoo, H.L.2    Gurevich, E.3    Joyce, J.N.4
  • 44
    • 20444379220 scopus 로고    scopus 로고
    • Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6, 10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9 -ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography
    • COI: 1:CAS:528:DC%2BD2MXkt1Wru78%3D, PID: 15943487
    • Wilson AA, McCormick P, Kapur S, Willeit M, Garcia A, Hussey D, Houle S, Seeman P, Ginovart N (2005) Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6, 10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9 -ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography. J Med Chem 48:4153
    • (2005) J Med Chem , vol.48 , pp. 4153
    • Wilson, A.A.1    McCormick, P.2    Kapur, S.3    Willeit, M.4    Garcia, A.5    Hussey, D.6    Houle, S.7    Seeman, P.8    Ginovart, N.9
  • 45
    • 0027185464 scopus 로고
    • Dopamine receptors labelled by PHNO
    • COI: 1:CAS:528:DyaK2cXht1GjtLs%3D, PID: 7902615
    • Seeman P, Ulpian C, Larsen RD, Anderson PS (1993) Dopamine receptors labelled by PHNO. Synapse 14:254–262
    • (1993) Synapse , vol.14 , pp. 254-262
    • Seeman, P.1    Ulpian, C.2    Larsen, R.D.3    Anderson, P.S.4
  • 46
    • 33344454906 scopus 로고    scopus 로고
    • High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO
    • COI: 1:CAS:528:DC%2BD28XhvVehurY%3D, PID: 16373068
    • Willeit M, Ginovart N, Kapur S, Houle S, Hussey D, Seeman P, Wilson AA (2006) High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO. Biol Psychiatry 59:389–394
    • (2006) Biol Psychiatry , vol.59 , pp. 389-394
    • Willeit, M.1    Ginovart, N.2    Kapur, S.3    Houle, S.4    Hussey, D.5    Seeman, P.6    Wilson, A.A.7
  • 55
    • 33745827777 scopus 로고    scopus 로고
    • Upregulation of dopamine D2 receptors in dopaminergic drug naïve patients with parkin gene mutations
    • PID: 16511856
    • Scherfler C, Khan NL, Pavese N, Lees AJ, Quinn NP, Brooks DJ, Piccini P (2006) Upregulation of dopamine D2 receptors in dopaminergic drug naïve patients with parkin gene mutations. Mov Disord 21(6):783–788
    • (2006) Mov Disord , vol.21 , Issue.6 , pp. 783-788
    • Scherfler, C.1    Khan, N.L.2    Pavese, N.3    Lees, A.J.4    Quinn, N.P.5    Brooks, D.J.6    Piccini, P.7
  • 57
    • 0033381760 scopus 로고    scopus 로고
    • Recent advances in atypical parkinsonian disorders
    • COI: 1:STN:280:DC%2BD3c%2Fit1Omuw%3D%3D, PID: 10555833
    • Litvan I (1999) Recent advances in atypical parkinsonian disorders. Curr Opin Neurol 12(4):441–446
    • (1999) Curr Opin Neurol , vol.12 , Issue.4 , pp. 441-446
    • Litvan, I.1
  • 59
    • 77950961958 scopus 로고    scopus 로고
    • The value of the dopamine D2/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes
    • PID: 20237026
    • la Fougère C, Pöpperl G, Levin J, Wängler B, Böning G, Uebleis C, Cumming P, Bartenstein P, Bötzel K, Tatsch K (2010) The value of the dopamine D2/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes. J Nucl Med 51(4):581–587
    • (2010) J Nucl Med , vol.51 , Issue.4 , pp. 581-587
    • la Fougère, C.1    Pöpperl, G.2    Levin, J.3    Wängler, B.4    Böning, G.5    Uebleis, C.6    Cumming, P.7    Bartenstein, P.8    Bötzel, K.9    Tatsch, K.10
  • 61
    • 54049120959 scopus 로고    scopus 로고
    • Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson’s disease: an in vivo 11C-raclopride PET study
    • COI: 1:CAS:528:DC%2BD1cXht12ns7%2FL, PID: 18723016
    • Politis M, Piccini P, Pavese N, Koh SB, Brooks DJ (2008) Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson’s disease: an in vivo 11C-raclopride PET study. Exp Neurol 214:112–116
    • (2008) Exp Neurol , vol.214 , pp. 112-116
    • Politis, M.1    Piccini, P.2    Pavese, N.3    Koh, S.B.4    Brooks, D.J.5
  • 63
    • 17644438752 scopus 로고    scopus 로고
    • Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson’s disease
    • COI: 1:CAS:528:DC%2BD3cXivFOitbw%3D, PID: 10751262
    • Kaasinen V, Någren K, Hietala J, Oikonen V, Vilkman H, Farde L, Halldin C, Rinne JO (2000) Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson’s disease. Neurology 54(7):1482–1487
    • (2000) Neurology , vol.54 , Issue.7 , pp. 1482-1487
    • Kaasinen, V.1    Någren, K.2    Hietala, J.3    Oikonen, V.4    Vilkman, H.5    Farde, L.6    Halldin, C.7    Rinne, J.O.8
  • 64
    • 0038521243 scopus 로고    scopus 로고
    • Extrastriatal dopamine D(2) receptors in Parkinson’s disease: a longitudinal study
    • COI: 1:CAS:528:DC%2BD3sXntlKhs78%3D, PID: 12768355
    • Kaasinen V, Aalto S, Nagren K, Hietala J, Sonninen P, Rinne JO (2003) Extrastriatal dopamine D(2) receptors in Parkinson’s disease: a longitudinal study. J Neural Transm 110(6):591–601
    • (2003) J Neural Transm , vol.110 , Issue.6 , pp. 591-601
    • Kaasinen, V.1    Aalto, S.2    Nagren, K.3    Hietala, J.4    Sonninen, P.5    Rinne, J.O.6
  • 65
    • 0344430080 scopus 로고    scopus 로고
    • Raclopride studies of dopamine release: dependence on presynaptic integrity
    • COI: 1:CAS:528:DC%2BD3sXpt1Wiu7k%3D, PID: 14643086
    • Doudet DJ, Holden JE (2003) Raclopride studies of dopamine release: dependence on presynaptic integrity. Biol Psychiatry 54:1193–1199
    • (2003) Biol Psychiatry , vol.54 , pp. 1193-1199
    • Doudet, D.J.1    Holden, J.E.2
  • 67
    • 0037312540 scopus 로고    scopus 로고
    • Dopamine release during sequential finger movements in health and Parkinson’s disease: a PET study
    • PID: 12538400
    • Goerendt IK, Messa C, Lawrence AD, Grasby PM, Piccini P, Brooks DJ (2003) Dopamine release during sequential finger movements in health and Parkinson’s disease: a PET study. Brain 126:312–325
    • (2003) Brain , vol.126 , pp. 312-325
    • Goerendt, I.K.1    Messa, C.2    Lawrence, A.D.3    Grasby, P.M.4    Piccini, P.5    Brooks, D.J.6
  • 68
    • 0029904201 scopus 로고    scopus 로고
    • Levodopa induced changes in synaptic dopamine in patients with Parkinson’s disease as measured by 11C-raclopride displacement and PET
    • COI: 1:STN:280:DyaK283ht1GrtQ%3D%3D, PID: 8628494
    • Tedroff J, Pederson M, Aquilonius SM, Hartvig P, Jacobsson G, Langstrom B (1996) Levodopa induced changes in synaptic dopamine in patients with Parkinson’s disease as measured by 11C-raclopride displacement and PET. Neurology 46:1430–1436
    • (1996) Neurology , vol.46 , pp. 1430-1436
    • Tedroff, J.1    Pederson, M.2    Aquilonius, S.M.3    Hartvig, P.4    Jacobsson, G.5    Langstrom, B.6
  • 69
    • 0038523950 scopus 로고    scopus 로고
    • Endogenous dopamine release after pharmacological challenges in Parkinson’s disease
    • COI: 1:CAS:528:DC%2BD3sXktVSnt78%3D, PID: 12730999
    • Piccini P, Pavese N, Brooks DJ (2003) Endogenous dopamine release after pharmacological challenges in Parkinson’s disease. Ann Neurol 53:647–653
    • (2003) Ann Neurol , vol.53 , pp. 647-653
    • Piccini, P.1    Pavese, N.2    Brooks, D.J.3
  • 71
    • 44949221767 scopus 로고    scopus 로고
    • Cognitive deficits and striatal-frontal dopamine release in Parkinson’s disease
    • PID: 18362097
    • Sawamoto N, Piccini P, Hotten G, Pavese N, Thielemans K, Brooks DJ (2008) Cognitive deficits and striatal-frontal dopamine release in Parkinson’s disease. Brain 131:1294–1302
    • (2008) Brain , vol.131 , pp. 1294-1302
    • Sawamoto, N.1    Piccini, P.2    Hotten, G.3    Pavese, N.4    Thielemans, K.5    Brooks, D.J.6
  • 72
    • 0035092779 scopus 로고    scopus 로고
    • Biochemical variations in the synaptic levels of dopamine precede motor fluctuations in Parkinson’s disease: PET evidence of increased dopamine turnover
    • PID: 11261503
    • de la Fuente-Fernandez R, Lu JQ, Sossi V, Jivan S, Schulzer M, Holden JE, Lee CS, Ruth TJ, Calne DB, Stoessl AJ (2001) Biochemical variations in the synaptic levels of dopamine precede motor fluctuations in Parkinson’s disease: PET evidence of increased dopamine turnover. Ann Neurol 49:298–303
    • (2001) Ann Neurol , vol.49 , pp. 298-303
    • de la Fuente-Fernandez, R.1    Lu, J.Q.2    Sossi, V.3    Jivan, S.4    Schulzer, M.5    Holden, J.E.6    Lee, C.S.7    Ruth, T.J.8    Calne, D.B.9    Stoessl, A.J.10
  • 74
    • 10344236071 scopus 로고    scopus 로고
    • Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson’s disease: implications for dyskinesias
    • PID: 15329355
    • de la Fuente-Fernandez R, Sossi V, Huang Z, Furtado S, Lu QR, Calne DB, Ruth TJ, Stoessl AJ (2004) Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson’s disease: implications for dyskinesias. Brain 127:2747–2754
    • (2004) Brain , vol.127 , pp. 2747-2754
    • de la Fuente-Fernandez, R.1    Sossi, V.2    Huang, Z.3    Furtado, S.4    Lu, Q.R.5    Calne, D.B.6    Ruth, T.J.7    Stoessl, A.J.8
  • 75
    • 33750975077 scopus 로고    scopus 로고
    • Clinical correlates of levodopa induced dopamine release in Parkinson’s disease: a PET study
    • COI: 1:CAS:528:DC%2BD28XhtFChsLnO, PID: 17101892
    • Pavese N, Evans AH, Tai YF, Hotton G, Brooks DJ, Lees AJ, Piccini P (2006) Clinical correlates of levodopa induced dopamine release in Parkinson’s disease: a PET study. Neurology 67:1612–1617
    • (2006) Neurology , vol.67 , pp. 1612-1617
    • Pavese, N.1    Evans, A.H.2    Tai, Y.F.3    Hotton, G.4    Brooks, D.J.5    Lees, A.J.6    Piccini, P.7
  • 85
    • 0026580695 scopus 로고
    • The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationships to other psychiatric disorders
    • COI: 1:STN:280:DyaK387mtV2ltw%3D%3D, PID: 1536268
    • McElroy SL, Hudson JI, Pope HJ, Keck PE, Aizley HG (1992) The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationships to other psychiatric disorders. Am J Psychiatry 149:318–327
    • (1992) Am J Psychiatry , vol.149 , pp. 318-327
    • McElroy, S.L.1    Hudson, J.I.2    Pope, H.J.3    Keck, P.E.4    Aizley, H.G.5
  • 86
    • 0034055187 scopus 로고    scopus 로고
    • Hedonistic homeostasis dysregulation in patients with Parkinson’s disease on dopamine replacement therapies
    • COI: 1:STN:280:DC%2BD3c7ptlOisQ%3D%3D, PID: 10727476
    • Giovannoni G, O’Sullivan JD, Turner K, Manson AJ, Lees AJ (2000) Hedonistic homeostasis dysregulation in patients with Parkinson’s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423–428
    • (2000) J Neurol Neurosurg Psychiatry , vol.68 , pp. 423-428
    • Giovannoni, G.1    O’Sullivan, J.D.2    Turner, K.3    Manson, A.J.4    Lees, A.J.5
  • 88
    • 66549083459 scopus 로고    scopus 로고
    • Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a 11C-raclopride PET study
    • COI: 1:STN:280:DC%2BD1MzisFWgsg%3D%3D, PID: 19346328
    • Steeves TDL, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, van Elmeren T, Rusjan P, Houle S, Strafella AP (2009) Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a 11C-raclopride PET study. Brain 132:1376–1385
    • (2009) Brain , vol.132 , pp. 1376-1385
    • Steeves, T.D.L.1    Miyasaki, J.2    Zurowski, M.3    Lang, A.E.4    Pellecchia, G.5    van Elmeren, T.6    Rusjan, P.7    Houle, S.8    Strafella, A.P.9
  • 89
    • 84880174056 scopus 로고    scopus 로고
    • Dopaminergic and clinical correlates of pathological gambling in Parkinson’s disease: a case report
    • PID: 23908610
    • Callesen MB, Hansen KV, Gjedde A, Linnet J, Møller A (2013) Dopaminergic and clinical correlates of pathological gambling in Parkinson’s disease: a case report. Front Behav Neurosci 7:95
    • (2013) Front Behav Neurosci , vol.7 , pp. 95
    • Callesen, M.B.1    Hansen, K.V.2    Gjedde, A.3    Linnet, J.4    Møller, A.5
  • 92
    • 84865300674 scopus 로고    scopus 로고
    • Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson’s patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study
    • COI: 1:CAS:528:DC%2BC38XhsVCjurfI, PID: 22766031
    • Ray NJ, Miyasaki JM, Zurowski M, Ko JH, Cho SS, Pellecchia G, Antonelli F, Houle S, Lang AE, Strafella AP (2012) Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson’s patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Neurobiol Dis 48(3):519–525
    • (2012) Neurobiol Dis , vol.48 , Issue.3 , pp. 519-525
    • Ray, N.J.1    Miyasaki, J.M.2    Zurowski, M.3    Ko, J.H.4    Cho, S.S.5    Pellecchia, G.6    Antonelli, F.7    Houle, S.8    Lang, A.E.9    Strafella, A.P.10
  • 93
    • 47549101673 scopus 로고    scopus 로고
    • Understanding the placebo effect. Part 2: underlying psychological and neurobiological processes
    • Howland RH (2008) Understanding the placebo effect. Part 2: underlying psychological and neurobiological processes. J Psychosoc Nurs Ment Health Serv 46(6):15–18
    • (2008) J Psychosoc Nurs Ment Health Serv , vol.46 , Issue.6 , pp. 15-18
    • Howland, R.H.1
  • 94
    • 71849111911 scopus 로고    scopus 로고
    • The placebo-reward hypothesis: dopamine and the placebo effect
    • de la Fuente-Fernandez R (2009) The placebo-reward hypothesis: dopamine and the placebo effect. Parkinsonism Relat Disord 15(3):72–74
    • (2009) Parkinsonism Relat Disord , vol.15 , Issue.3 , pp. 72-74
    • de la Fuente-Fernandez, R.1
  • 95
    • 85019270779 scopus 로고
    • The pharmacology of placebos
    • Wolf S (1959) The pharmacology of placebos. J Am Med Assoc 159:1602–1606
    • (1959) J Am Med Assoc , vol.159 , pp. 1602-1606
    • Wolf, S.1
  • 96
    • 0033405084 scopus 로고    scopus 로고
    • The placebo response in Parkinson’s disease. Parkinson Study Group
    • COI: 1:STN:280:DyaK1MzntVygtQ%3D%3D, PID: 10442249
    • Shetty N, Friedman JH, Kieburtz K, Marshall FJ, Oakes D (1999) The placebo response in Parkinson’s disease. Parkinson Study Group. Clin Neuropharmacol 22(4):207–212
    • (1999) Clin Neuropharmacol , vol.22 , Issue.4 , pp. 207-212
    • Shetty, N.1    Friedman, J.H.2    Kieburtz, K.3    Marshall, F.J.4    Oakes, D.5
  • 97
    • 0035838997 scopus 로고    scopus 로고
    • Expectation and dopamine release: mechanisms of the placebo effect in Parkinson’s disease
    • PID: 11498597
    • de la Fuente-Fernandez R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ (2001) Expectation and dopamine release: mechanisms of the placebo effect in Parkinson’s disease. Science 293:1164–1166
    • (2001) Science , vol.293 , pp. 1164-1166
    • de la Fuente-Fernandez, R.1    Ruth, T.J.2    Sossi, V.3    Schulzer, M.4    Calne, D.B.5    Stoessl, A.J.6
  • 100
    • 84879929197 scopus 로고    scopus 로고
    • Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson’s disease
    • COI: 1:CAS:528:DC%2BC3sXptVOiu7c%3D, PID: 23636255
    • Fisher BE, Li Q, Nacca A, Salem GJ, Song J, Yip J, Hui JS, Jakowec MW, Petzinger GM (2013) Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson’s disease. Neuroreport 24(10):509–514
    • (2013) Neuroreport , vol.24 , Issue.10 , pp. 509-514
    • Fisher, B.E.1    Li, Q.2    Nacca, A.3    Salem, G.J.4    Song, J.5    Yip, J.6    Hui, J.S.7    Jakowec, M.W.8    Petzinger, G.M.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.